Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Latest preclinical data further supports antiasthmatic efficacy of betotastine besilate

Oct. 28, 1998

New antiasthmatic agent launched in Italy by Zeneca, Chiesi and Recordati

Oct. 27, 1998

FDA grants fast track status to Surfaxin in MAS

Oct. 26, 1998

Fournier characterizes potent and selective human bradykinin B2 antagonist in vitro

Oct. 23, 1998

Antiallergic/antiinflammatory compounds in development at Nikken Chemicals

Oct. 21, 1998

Phase II trial of tgAAV-CF completed, preliminary data presented at CF conference

Oct. 20, 1998

Positive phase I safety and efficacy results reported for INS-365

Oct. 20, 1998

Gene-based CF therapeutic developed by Megabios and Glaxo Wellcome proves safe in humans

Oct. 20, 1998

FDA awards fast track status and development grant to Surfaxin

Oct. 20, 1998

New U.S. patent covers use of anti-CTGF antibodies to treat fibrotic disorders

Oct. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...